🟢 Krystal Biotech is trading 4.5% up in after-hours trading; no company-specific catalyst identified

Krystal Biotech is trading 4.52% up in after-hours at $335.69, with no new company-specific announcement identified to explain the rise.

• The regular-session close was $321.16 on October 13, 2026.
• A report published October 13 noted a consensus Buy rating from 14 analysts but did not link the coverage to the after-hours move.
• The broader market was mixed, with no clear evidence that market direction explains the increase.